Table 1.
Baseline characteristics of patients at the start of high-volume hemofiltration
| Patient | Diagnosis | APACHE II score | SOFA score | Survival (day 28) |
MAP, mm Hg |
NE dose, μg/kg per min | CI, L/min per m2 |
SmvO2, percentage |
Lactate, mmol/L |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Cholangitis | 34 | 13 | Yes | 70 | 0.30 | 3 | 49 | 6 |
| 2 | Necrotizing fasceitis | 24 | 10 | Yes | 67 | 0.56 | 5.5 | 79 | 4.7 |
| 3 | Cholangitis | 25 | 11 | Yes | 65 | 0.50 | 5.3 | 76 | 8.3 |
| 4 | Catheter related sepsis | 31 | 15 | No | 70 | 0.60 | 3.1 | 71 | 4.1 |
| 5 | Diverticulitis | 19 | 14 | Yes | 75 | 0.37 | 5.5 | 80 | 2.6 |
| 6 | Peritonitis | 19 | 11 | No | 64 | 0.30 | 4.4 | 61 | 6.7 |
| 7 | Pneumonia | 21 | 13 | Yes | 74 | 0.50 | 3.1 | 58 | 2.6 |
| 8 | Necrotizing fasceitis | 25 | 13 | No | 64 | 1.00 | 4.8 | 79 | 4.5 |
| 9 | Pyonephrosis | 23 | 13 | Yes | 66 | 0.28 | 3.5 | 71 | 3.6 |
| 10 | Mesenteric ischemia | 23 | 13 | Yes | 62 | 0.62 | 3.4 | 78 | 2.6 |
| 11 | Empyema | 27 | 14 | No | 63 | 0.30 | 4.8 | 96 | 13 |
| 12 | Endocarditis | 25 | 15 | No | 70 | 0.60 | 3 | 70 | 5.8 |
| Mean | 24.7 | 12.8 | 67.5 | 0.49 | 4.1 | 72 | 5.4 | ||
| SD | 4.4 | 1.7 | 4.3 | 0.21 | 1.0 | 11 | 3.0 | ||
APACHE II, Acute Physiology and Chronic Health Evaluation II; CI, cardiac index; MAP, mean arterial pressure; NE, norepinephrine; SD, standard deviation; SmvO2, mixed venous oxygen saturation; SOFA, Sequential Organ Failure Assessment.